TY - JOUR
T1 - Direct activation of the phosphatidylinositol 3′-kinase by the insulin receptor
AU - Van Horn, Debra J.
AU - Myers, Martin G.
AU - Backer, Jonathan M.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1994/1/7
Y1 - 1994/1/7
N2 - We have previously shown that phosphatidylinositol (PtdIns) 3′-kinase is activated by the binding of proteins or peptides containing the phosphorylated motif Y(P)XXM. In the present study, we examine interactions between Ptdlns 3′-kinase and the human insulin receptor, which contains a C-terminal phosphorylation site in the sequence Y1322THM. Partially purified insulin receptors bound tightly to bacterial fusion proteins containing the N- or C-terminal SH2 domains from Ptdlns 3′-kinase regulatory subunit (p85). In contrast, a mutant insulin receptor, truncated by 43 amino acids at the C terminus (IRΔCT), bound poorly to the SH2 domains; these mutant receptors have normal kinase activity but lack the Y1322THM motif. Similarly, incubation with wild-type receptors increased the activity of immunopurified Ptdlns 3′-kinase, whereas incubation with IRΔCT receptors did not affect Ptdlns 3′-kinase activity. Activation of Ptdlns 3′-kinase by the wild-type receptor was mimicked by a tyrosyl phosphopeptide derived from the insulin receptor C terminus and containing the Y1322THM motif; non-phosphorylated peptide did not affect activity. Thus, the insulin receptor C terminus activates Ptdlns 3′-kinase in vitro by binding to the SH2 domains of the 85-kDa regulatory subunit. These data support the hypothesis that binding of tyrosyl-phosphorylated receptors to p85 SH2 domains is a general mechanism for Ptdlns 3′-kinase activation, and they suggest that direct interactions between the insulin receptor and Ptdlns 3′-kinase may provide an alternative pathway for the activation of this enzyme by insulin.
AB - We have previously shown that phosphatidylinositol (PtdIns) 3′-kinase is activated by the binding of proteins or peptides containing the phosphorylated motif Y(P)XXM. In the present study, we examine interactions between Ptdlns 3′-kinase and the human insulin receptor, which contains a C-terminal phosphorylation site in the sequence Y1322THM. Partially purified insulin receptors bound tightly to bacterial fusion proteins containing the N- or C-terminal SH2 domains from Ptdlns 3′-kinase regulatory subunit (p85). In contrast, a mutant insulin receptor, truncated by 43 amino acids at the C terminus (IRΔCT), bound poorly to the SH2 domains; these mutant receptors have normal kinase activity but lack the Y1322THM motif. Similarly, incubation with wild-type receptors increased the activity of immunopurified Ptdlns 3′-kinase, whereas incubation with IRΔCT receptors did not affect Ptdlns 3′-kinase activity. Activation of Ptdlns 3′-kinase by the wild-type receptor was mimicked by a tyrosyl phosphopeptide derived from the insulin receptor C terminus and containing the Y1322THM motif; non-phosphorylated peptide did not affect activity. Thus, the insulin receptor C terminus activates Ptdlns 3′-kinase in vitro by binding to the SH2 domains of the 85-kDa regulatory subunit. These data support the hypothesis that binding of tyrosyl-phosphorylated receptors to p85 SH2 domains is a general mechanism for Ptdlns 3′-kinase activation, and they suggest that direct interactions between the insulin receptor and Ptdlns 3′-kinase may provide an alternative pathway for the activation of this enzyme by insulin.
UR - http://www.scopus.com/inward/record.url?scp=0028012445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028012445&partnerID=8YFLogxK
M3 - Article
C2 - 8276809
AN - SCOPUS:0028012445
SN - 0021-9258
VL - 269
SP - 29
EP - 32
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 1
ER -